Joy E. Marlo

Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists

Signalling bias in new drug discovery: detection, quantification and therapeutic impact

Trends in GPCR drug discovery: new agents, targets and indications

Allosteric Modulation of Family C G-Protein-Coupled Receptors: from Molecular Insights to Therapeutic Perspectives

Computational Methods in Drug Discovery

Molecular Dynamics Simulation for All

International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update

Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor

Computational approaches in target identification and drug discovery

Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders

The structure and function of G-protein-coupled receptors

Unraveling the therapeutic potential of the Hedgehog pathway in cancer

Artificial intelligence in drug development: present status and future prospects

How were new medicines discovered?

The use of spirocyclic scaffolds in drug discovery

Facile Diversity-Oriented Synthesis and Antitubercular Evaluation of Novel Aryl and Heteroaryl Tethered Pyridines and Dihydro-6H-quinolin-5-ones Derived via Variants of the Bohlmann–Rahtz Reaction

M1 muscarinic acetylcholine receptor in Alzheimer’s disease

Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders

Structure and dynamics of the M3 muscarinic acetylcholine receptor

Spirocyclic replacements for the isatin in the highly selective, muscarinic M1 PAM ML137: The continued optimization of an MLPCN probe molecule

Development of allosteric modulators of GPCRs for treatment of CNS disorders

Molecular Docking and Structure-Based Drug Design Strategies

DAMP-sensing receptors in sterile inflammation and inflammatory diseases

Molecular Docking: Shifting Paradigms in Drug Discovery

The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors

The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease

Microglial M1/M2 polarization and metabolic states

Metal-Free Multicomponent Syntheses of Pyridines

G Protein–Coupled Receptors Revisited: Therapeutic Applications Inspired by Synthetic Biology

Discovery of the First Highly M5-Preferring Muscarinic Acetylcholine Receptor Ligand, an M5 Positive Allosteric Modulator Derived from a Series of 5-Trifluoromethoxy N -Benzyl Isatins

Discovery and Characterization of Novel Allosteric Potentiators of M1 Muscarinic Receptors Reveals Multiple Modes of Activity

Discovery of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Reveals Chemical and Functional Diversity and In Vivo Activity in Rat Behavioral Models of Anxiolytic and Antipsychotic Activity

Discovery, Characterization, and Antiparkinsonian Effect of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4